A group of men and women who are members of ConDUC
This partnership will break down barriers and build solutionsImage by: ConDUC
A group of men and women who are members of ConDUC
11 March 2026

Strengthening Prostate Cancer for Black Men: Movember and ConDUC Partner to Strengthen Informed Decision-Making

Movember
3 minutes read time

Movember is proud to partner with the Consortium on Disparities of Urologic Conditions (ConDUC) to improve prostate cancer care for Black men in the United States. In the United States, prostate cancer remains one of the most common cancers among men and has far reaching distressing implications for quality of life, sexual health, and long-term survivorship. Prostate cancer does not impact all communities in the same way. One in six Black men2 in the United States will be diagnosed with prostate cancer during their lifetime, compared to one in eight White men. Black men are also more likely to be diagnosed at younger ages and experience worse outcomes, including higher mortality, and they experience worse sexual health side effects of prostate cancer treatment than White men1. The partnership will focus specifically on sexual health in prostate cancer, one of the most common and life-altering quality of life challenges men face after treatment, which can also mean challenges in intimacy and relationships.

In November 2025, Movember and ConDUC ran a workshop in Atlanta, Georgia with over a dozen clinicians and community health partners to explore the development of a new tool that can be used by physicians, patients and their partners focused on the sexual-health impact after prostate cancer treatment, specifically designed for Black men. The session was shaped through collaboration with facilitators and supported by the leadership of Rebecca Dabbs, Cancer Implementation Director for the U.S. market and Jen Edgecombe, Movember’s Global Director of Sexual Health & Wellbeing. The workshop brought together clinicians, advisors, and partners committed to improving communication, trust, and care experiences for patients and their families.

A Collaborative Approach to Better Care

The workshop underscored a shared commitment to understanding what Black men need during diagnosis, treatment, and life after prostate cancer. Together, Movember and ConDUC explored opportunities to strengthen conversations about sexual health, treatment impacts, quality of life, and relationship wellbeing. Movember partners and clinicians emphasized the importance of assets that are representative of the cultural and background of the patients, and tools that support both clinicians and patients in navigating complex decisions. Modern medicine has come a long way when it comes to prostate cancer treatment and there are many ways to treat prostate cancer, which can sometimes feel overwhelming. There are also many factors which shape a man’s treatment plan—from the stage and type of cancer to knowing the side-effects of different treatments. Not all men will have all options. But if they do, they should be given the opportunity to choose what’s best for them and their beliefs and lifestyles.

Building Toward the Next Phase

Insights from the workshop are helping shape the next phase of work, where Movember and ConDUC will continue collaborating with men and partners, and clinical and community experts to design a resource that is practical, meaningful, and grounded in the realities of care for Black men.

Your Funds in Action

We’re proud to be using funds raised by the Movember community across the United States to power homegrown projects. By working alongside trusted leaders like ConDUC, Movember is helping build solutions that can break down barriers, improve provider–patient conversations, and support better outcomes for men affected by prostate cancer.

References:

1. Burnett AL. Racial Disparities in Sexual Dysfunction Outcomes After Prostate Cancer Treatment: Myth or Reality? J Racial Ethn Health Disparities. 2016 Mar;3(1):154-9. doi: 10.1007/s40615-015-0126-7. Epub 2015 May 28. PMID: 26896115.

2. Kratzer TB, Mazzitelli N, Star J. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75:485–497. doi:10.3322/caac.70028.